Risk factor analysis of cerebral white matter hyperintensities in children with sickle cell disease

British Journal of Haematology

Volumn 172, Issue 2, 2016, Pages 274-284

  van der Land, Veronica ^a   Mutsaerts, Henri J M M ^b   Engelen, Marc ^a   Heijboer, Harriët ^a   Roest, Mark ^c   Hollestelle, Martine J ^d   Kuijpers, Taco W ^a   Nederkoorn, Paul J ^b   Cnossen, Marjon H ^e   Majoie, Charles B L M ^b   Nederveen, Aart J ^b   Fijnvandraat, Karin ^a  

^a EMMA CHILDREN S HOSPITAL   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d Sanquin Diagnostiek   (Netherlands)

^e SOPHIA CHILDREN S HOSPITAL   (Netherlands)

Author keywords

Cerebral blood flow; Sickle cell disease; White matter hyperintensities

Indexed keywords

HEMOGLOBIN F;

ADOLESCENT; BLOOD; BLOOD CLOTTING; BRAIN CIRCULATION; CEREBRAL INFARCTION; CHILD; COMPLICATION; FEMALE; HUMAN; MALE; METABOLISM; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; PROSPECTIVE STUDY; RISK FACTOR; SEX DIFFERENCE; SICKLE CELL ANEMIA; VASCULAR ENDOTHELIUM; WHITE MATTER;

ADOLESCENT; ANEMIA, SICKLE CELL; BLOOD COAGULATION; CEREBRAL INFARCTION; CEREBROVASCULAR CIRCULATION; CHILD; ENDOTHELIUM, VASCULAR; FEMALE; FETAL HEMOGLOBIN; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; PROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS; WHITE MATTER;

EID: 84954028324     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.13819     Document Type: Article

References (56)

1. Adams, R.J., McKie, V.C., Hsu, L., Files, B., Vichinsky, E., Pegelow, C., Abboud, M., Gallagher, D., Kutlar, A., Nichols, F.T., Bonds, D.R. & Brambilla, D. (1998) Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. The New England Journal of Medicine, 339, 5-11.
2. Alsop, D.C., Detre, J.A., Golay, X., Günther, M., Hendrikse, J., Hernandez-Garcia, L., Lu, H., Macintosh, B.J., Parkes, L.M., Smits, M., van Osch, M.J.P., Wang, D.J.J., Wong, E.C. & Zaharchuk, G. (2014) Recommended implementation of arterial spin-labeled perfusion MRI for clinical applications: a consensus of the ISMRM perfusion study group and the European consortium for ASL in dementia. Magnetic Resonance in Medicine, 73, 102-116.
3. Arkuszewski, M., Krejza, J., Chen, R. & Melhem, E.R. (2013) Sickle cell anemia: reference values of cerebral blood flow determined by continuous arterial spin labeling MRI. The Neuroradiology Journal, 26, 191-200.
4. Armstrong, F.D., Thompson, R.J., Wang, W., Zimmerman, R., Pegelow, C.H., Miller, S., Moser, F., Bello, J., Hurtig, A. & Vass, K. (1996) Cognitive functioning and brain magnetic resonance imaging in children with sickle cell disease. Pediatrics, 97, 864-870.
5. Ashburner, J. (2007) A fast diffeomorphic image registration algorithm. NeuroImage, 38, 95-113.
6. Aslan, S., Xu, F., Wang, P.L., Uh, J., Yezhuvath, U.S., van Osch, M. & Lu, H. (2010) Estimation of labeling efficiency in pseudocontinuous arterial spin labeling. Magnetic Resonance in Medicine: Official Journal of the Society of Magnetic Resonance in Medicine/Society of Magnetic Resonance in Medicine, 63, 765-771.
7. Bailey, K., Morris, J.S., Thomas, P. & Serjeant, G.R. (1992) Fetal haemoglobin and early manifestations of homozygous sickle cell disease. Archives of Disease in Childhood, 67, 517-520.
8. Belcher, J.D., Chen, C., Nguyen, J., Milbauer, L., Abdulla, F., Alayash, A.I., Smith, A., Nath, K.A., Hebbel, R.P. & Vercellotti, G.M. (2014) Heme triggers TLR4 signaling leading to endothelial cell activation and vaso-occlusion in murine sickle cell disease. Blood, 123, 377-390.
9. Bernaudin, F., Verlhac, S., Arnaud, C., Kamdem, A., Chevret, S., Hau, I., Coïc, L., Leveillé, E., Lemarchand, E., Lesprit, E., Abadie, I., Medejel, N., Madhi, F., Lemerle, S., Biscardi, S., Bardakdjian, J., Galactéros, F., Torres, M., Kuentz, M., Ferry, C., Socié, G., Reinert, P. & Delacourt, C. (2011) Impact of early transcranial Doppler screening and intensive therapy on cerebral vasculopathy outcome in a newborn sickle cell anemia cohort. Blood, 117, 1130-1140.
10. Bernaudin, F., Verlhac, S., Arnaud, C., Kamdem, A., Vasile, M., Kasbi, F., Hau, I., Madhi, F., Fourmaux, C., Biscardi, S., Epaud, R. & Pondarré, C. (2015) Chronic and acute anemia and extracranial internal carotid stenosis are risk factors for silent cerebral infarcts in sickle cell anemia. Blood, 125, 1653-1661.
11. Bhatnagar, P., Keefer, J.R., Casella, J.F., Barron-casella, E.A., Bean, C.J., Hooper, C.W., Payne, A.B., Arking, D.E. & Debaun, M.R. (2013) Association between baseline fetal hemoglobin levels and incidence of severe vaso-occlusive pain episodes in children with sickle cell anemia. Pediatric Blood & Cancer, 60, 12-14.
12. Borchiellini, A., Fijnvandraat, K., Ten Cate, J., Pajkrt, D., Van Deventer, S., Pasterkamp, G., Meijer-huizinga, F., Zwart-huinink, L., Voorberg, J. & Van Mourik, J. (1996) Quantitative analysis of von Willebrand factor propeptide release in vivo: effect of experimental endotoxemia and administration of 1- deamino-8-D-arginine vasopressin in humans. Blood, 88, 2951-2958.
13. Casella, J.F., King, A.A., Barton, B., White, D.A., Noetzel, M.J., Ichord, R.N., Terrill, C., Hirtz, D., Mckinstry, R.C., Strouse, J.J., Howard, T.H., Coates, T.D., Minniti, C.P., Campbell, A.D., Vendt, B.A., Lehman, H. & DeBaun, M.R. (2010) Design of the silent cerebral infarct transfusion (SIT) trial. Pediatric Hematology and Oncology, 27, 69-89.
14. Castro, O., Brambilla, D.J., Thorington, B., Reindorf, C.A., Scott, R.B., Gillette, P., Vera, J.C. & Levy, P.S. (1994) The acute chest syndrome in sickle cell disease: incidence and risk factors. Blood, 84, 643-649.
15. Cejka, J. (1982) Enzyme immunoassay for factor VIII-related antigen. Clinical Chemistry, 28, 1356-1358.
16. Chabriat, H., Joutel, A., Dichgans, M., Tournier-Lasserve, E. & Bousser, M.-G. (2009) Cadasil. Lancet Neurology, 8, 643-653.
17. Charache, S., Terrin, M.L., Moore, R.D., Dover, G.J., Barton, F.B., Eckert, S.V., McMahon, R.P. & Bonds, D.R. (1995) Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. The New England Journal of Medicine, 332, 1317-1322.
18. Chen, J., Hobbs, W.E., Le, J., Lenting, P.J., de Groot, P.G. & López, J.A. (2011) The rate of hemolysis in sickle cell disease correlates with the quantity of active von Willebrand factor in the plasma. Blood, 117, 3680-3683.
19. Colombatti, R., De Bon, E., Bertomoro, A., Casonato, A., Pontara, E., Omenetto, E., Saggiorato, G., Steffan, A., Damian, T., Cella, G., Teso, S., Manara, R., Rampazzo, P., Meneghetti, G., Basso, G., Sartori, M.T. & Sainati, L. (2013) Coagulation activation in children with sickle cell disease is associated with cerebral small vessel vasculopathy. PLoS ONE, 8, e78801.
20. Connes, P., Verlhac, S. & Bernaudin, F. (2013) Advances in understanding the pathogenesis of cerebrovascular vasculopathy in sickle cell anaemia. British Journal of Haematology, 161, 484-498.
21. De Vis, J.B., Hendrikse, J., Groenendaal, F., de Vries, L.S., Kersbergen, K.J., Benders, M.J.N.L. & Petersen, E.T. (2014) Impact of neonate haematocrit variability on the longitudinal relaxation time of blood: implications for arterial spin labelling MRI. NeuroImage. Clinical, 4, 517-525.
22. DeBaun, M.R., Sarnaik, S.A., Rodeghier, M.J., Minniti, C.P., Howard, T.H., Iyer, R.V., Inusa, B., Telfer, P.T., Kirby-Allen, M., Quinn, C.T., Bernaudin, F., Airewele, G., Woods, G.M., Panepinto, J.A., Fuh, B., Kwiatkowski, J.K., King, A.A., Rhodes, M.M., Thompson, A.A., Heiny, M.E., Redding-Lallinger, R.C., Kirkham, F.J., Sabio, H., Gonzalez, C.E., Saccente, S.L., Kalinyak, K.A., Strouse, J.J., Fixler, J.M., Gordon, M.O., Miller, J.P., Noetzel, M.J., Ichord, R.N. & Casella, J.F. (2012) Associated risk factors for silent cerebral infarcts in sickle cell anemia: low baseline hemoglobin, sex, and relative high systolic blood pressure. Blood, 119, 3684-3690.
23. Dowling, M.M., Quinn, C.T., Rogers, Z.R. & Buchanan, G.R. (2010) Acute silent cerebral infarction in children with sickle cell anemia. Pediatric Blood & Cancer, 54, 461-464.
24. Gruber, E.M., Jonas, R.A., Newburger, J.W., Zurakowski, D., Hansen, D.D. & Laussen, P.C. (1999) The effect of hematocrit on cerebral blood flow velocity in neonates and infants undergoing deep hypothermic cardiopulmonary bypass. Anesthesia and Analgesia, 89, 322-327.
25. Heijtel, D.F.R., Mutsaerts, H.J.M.M., Bakker, E., Schober, P., Stevens, M.F., Petersen, E.T., van Berckel, B.N.M., Majoie, C.B.L.M., Booij, J., van Osch, M.J.P., Vanbavel, E., Boellaard, R., Lammertsma, A.A. & Nederveen, A.J. (2002) Accuracy and precision of pseudo-continuous arterial spin labeling perfusion during baseline and hypercapnia: a head-to-head comparison with 15O H2O positron emission tomography. NeuroImage, 92, 182-192.
26. Helton, K.J., Paydar, A., Glass, J., Weirich, E.M., Hankins, J., Li, C., Smeltzer, M.P., Wang, W.C., Ware, R.E. & Ogg, R.J. (2009) Arterial spin-labeled perfusion combined with segmentation techniques to evaluate cerebral blood flow in white and gray matter of children with sickle cell anemia. Pediatric Blood Cancer, 52, 85-91.
27. Hoek, J.A., Sturk, A., ten Cate, J.W., Lamping, R.J., Berends, F. & Borm, J.J. (1988) Laboratory and clinical evaluation of an assay of thrombin-antithrombin III complexes in plasma. Clinical Chemistry, 34, 2058-2062.
28. Hyseni, A., Kemperman, H., de Lange, D.W., Kesecioglu, J., de Groot, P.G. & Roest, M. (2014) Active von Willebrand factor predicts 28-day mortality in patients with systemic inflammatory response syndrome. Blood, 123, 2153-2156.
29. Kitchen, L., Westmacott, R., Friefeld, S., MacGregor, D., Curtis, R., Allen, A., Yau, I., Askalan, R., Moharir, M., Domi, T. & DeVeber, G. (2012) The pediatric stroke outcome measure: a validation and reliability study. Stroke, 43, 1602-1608.
30. Koshy, M., Thomas, C. & Goodwin, J. (1990) Vascular lesions in the central nervous system in sickle cell disease (neuropathology). Journal of the Association for Academic Minority Physicians: The Official Publication of the Association for Academic Minority Physicians, 1, 71-78.
31. Kostousov, V., Fehr, J. & Bombeli, T. (2006) Novel, semi-automated, 60-min-assay to determine von Willebrand factor cleaving activity of ADAMTS-13. Thrombosis Research, 118, 723-731.
32. Kwiatkowski, J.L., Zimmerman, R.A., Pollock, A.N., Seto, W., Smith-Whitley, K., Shults, J., Blackwood-Chirchir, A. & Ohene-Fremping, K. (2009) Silent infarcts in young children with sickle cell disease. British Journal of Haematology, 146, 300-305.
33. van der Land, V., Peters, M., Biemond, B.J., Heijboer, H., Harteveld, C.L. & Fijnvandraat, K. (2013) Markers of endothelial dysfunction differ between subphenotypes in children with sickle cell disease. Thrombosis Research, 132, 712-717.
34. van der Land, V., Hijmans, C.T., de Ruiter, M., Mutsaerts, H.J.M.M., Cnossen, M.H., Engelen, M., Majoie, C.B.L.M., Nederveen, A.J., Grootenhuis, M.A. & Fijnvandraat, K. (2015) Volume of white matter hyperintensities is an independent predictor of intelligence quotient and processing speed in children with sickle cell disease. British Journal of Haematology, 168, 553-556.
35. Lavallée, P.C., Labreuche, J., Faille, D., Huisse, M. & Nicaise-Roland, P. (2013) Circulating markers of endothelial dysfunction and platelet activation in patients with severe symptomatic cerebral small vessel disease. Cerebrovascular Diseases, 36, 131-138.
36. Manwani, D. & Frenette, P.S. (2013) Vaso-occlusion in sickle cell disease: pathophysiology and novel targeted therapies. Blood, 122, 3892-3898.
37. Maumet, C., Maurel, P., Ferré, J.-C. & Barillot, C. (2014) Robust estimation of the cerebral blood flow in arterial spin labelling. Magnetic Resonance Imaging, 32, 497-504.
38. Muizelaar, J.P., Bouma, G.J., Levasseur, J.E. & Kontos, H.A. (1992) Effect of hematocrit variations on cerebral blood flow and basilar artery diameter in vivo. American Journal of Physiology - Heart and Circulatory Physiology, 262, H949-H954.
39. National High Blood Pressure Education Program Working Group. (2004) The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics, 114, 555-576.
40. Nur, E., Van Beers, E.J., Martina, S., Cuccovillo, I., Otten, H., Schnog, J.B., Meijers, J.C.M., Mantovani, A., Brandjes, D.P., Bottazzi, B. & Biemond, B.J. (2011) Plasma levels of pentraxin-3, an acute phase protein, are increased during sickle cell painful crisis. Blood Cells, Molecules, and Diseases, 46, 189-194.
41. Oguz, K.K., Golay, X., Pizzini, F.B., Freer, C.A., Ichord, R., Casella, J.F., van Zijl, P.C.M. & Melhem, E.R. (2003) Radiology sickle cell disease : continuous arterial spin-labeling perfusion mr imaging in children. Radiology, 227, 567-574.
42. Pegelow, C.H., Macklin, E.A., Moser, F.G., Wang, W.C., Bello, J.A., Miller, S.T., Vichinsky, E.P., DeBaun, M.R., Guarini, L., Zimmerman, R.A., Younkin, D.P., Gallagher, D.M. & Kinney, T.R. (2002) Longitudinal changes in brain magnetic resonance imaging findings in children with sickle cell disease. Blood, 99, 3014-3018.
43. Pelzer, H., Schwarz, A. & Stüber, W. (1991) Determination of human prothrombin activation fragment 1 + 2 in plasma with an antibody against a synthetic peptide. Thrombosis and Haemostasis, 65, 153-159.
44. Platt, O.S., Thorington, B.D., Brambilla, D.J., Milner, P.F., Rosse, W.F., Vichinsky, E. & Kinney, T.R. (1991) Pain in sickle cell disease. The New England Journal of Medicine, 325, 11-16.
45. Platt, O.S., Brambilla, D.J., Rosse, W.F., Milner, P.F., Castro, O., Steinberg, M.H. & Klug, P.P. (1994) Mortality in sickle cell disease. The New England Journal of Medicine, 330, 1639-1644.
46. Prohovnik, I., Hurlet-Jensen, A., Adams, R., De Vivo, D. & Pavlakis, S.G. (2009) Hemodynamic etiology of elevated flow velocity and stroke in sickle-cell disease. Journal of Cerebral Blood Flow and Metabolism, 29, 803-810.
47. Rombach, S.M., Twickler, T.B., Aerts, J.M.F.G., Linthorst, G.E., Wijburg, F.A. & Hollak, C.E.M. (2010) Vasculopathy in patients with Fabry disease: current controversies and research directions. Molecular Genetics and Metabolism, 99, 99-108.
48. Rouhl, R., Damoiseaux, J., Lodder, J., Theunissen, R., Knottnerus, I.L.H., Staals, J., Henskens, L.H.G., Kroon, A.A., de Leeuw, P.W., Willem, J., Tervaert, C. & Van Oostenbrugge, R.J. (2012) Vascular inflammation in cerebral small vessel disease. Neurobiology of Aging, 33, 1800-1806.
49. Schatz, J., Brown, R.T., Pascual, J.M., Hsu, L. & Debaun, M.R. (2001) Poor school and cognitive functioning with silent cerebral infarcts and sickle cell disease. Neurology, 56, 1109-1111.
50. Steinberg, M.H., Chui, D.H.K., Dover, G.J., Sebastiani, P. & Alsultan, A. (2014) Fetal hemoglobin in sickle cell anemia : a glass half full ? Blood, 123, 481-485.
51. Thomas, D.J., Marshall, J., Russell, R.W., Wetherley-Mein, G., du Boulay, G.H., Pearson, T.C., Symon, L. & Zilkha, E. (1977) Effect of haematocrit on cerebral blood-flow in man. Lancet, 2, 941-943.
52. Wang, J., Alsop, D.C., Li, L., Listerud, J., Gonzalez-At, J.B., Schnall, M.D. & Detre, J.A. (2002) Comparison of quantitative perfusion imaging using arterial spin labeling at 1.5 and 4.0 Tesla. Magnetic Resonance in Medicine, 48, 242-254.
53. Wang, W.C., Ware, R.E., Miller, S.T., Iyer, R.V., Casella, J.F., Minniti, C.P., Rana, S., Thornburg, C.D., Rogers, Z.R., Kalpatthi, R.V., Barredo, J.C., Brown, R.C., Sarnaik, S.A., Howard, T.H., Wynn, L.W., Kutlar, A. & Armstrong, F.D. (2011) Hydroxycarbamide in very young children with sickle-cell anaemia : a multicentre, randomised, controlled trial (BABY HUG). The Lancet, 377, 1663-1672.
54. Wardlaw, J.M., Smith, E.E., Biessels, G.J., Cordonnier, C., Fazekas, F., Frayne, R., Lindley, R.I., Brien, J.T.O., Doubal, F., Duering, M., Fox, N.C., Greenberg, S., Hachinski, V., Kilimann, I., Mok, V., van Oostenbrugge, R., Pantoni, L., Speck, O., Stephan, B.C.M., Teipel, S., Viswanathan, A., Werring, D., Chen, C., Smith, C., Van Buchem, M., Norrving, B., Gorelick, P.B. & Dichgans, M. (2013a) Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. The Lancet Neurology, 12, 822-838.
55. Wardlaw, J.M., Smith, C. & Dichgans, M. (2013b) Mechanisms of sporadic cerebral small vessel disease: insights from neuroimaging. The Lancet Neurology, 12, 483-497.
56. Yushkevich, P.A., Piven, J., Hazlett, H.C., Smith, R.G., Ho, S., Gee, J.C. & Gerig, G. (2006) User-guided 3D active contour segmentation of anatomical structures: significantly improved efficiency and reliability. NeuroImage, 31, 1116-1128.